Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants During SOF/LDV Combination Therapy Against Genotype 1b Hepatitis C Virus (HCV)
Scientific Reports - United Kingdom
doi 10.1038/s41598-017-15007-2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 31, 2017
Authors
Publisher
Springer Science and Business Media LLC